Newsroom archive

14 . 12 .2021
Press release
Addressing gaps in acne management: New expert recommendations to optimize patient care
  • Global release
READ MORE
13 . 12 .2021
Press release
Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners
  • U.S. release
READ MORE
08 . 12 .2021
Press release
Galderma announces relocation of U.S. Headquarters to downtown Dallas
  • U.S. release
READ MORE
07 . 12 .2021
Press release
Maria Teresa Hilado to join Galderma’s Advisory Committee
  • Global release
READ MORE
03 . 12 .2021
Press release
Galderma announces new data demonstrating the positive anti-inflammatory effect and mode of action of nemolizumab in patients with moderate to severe Prurigo Nodularis
  • Global release
READ MORE
29 . 11 .2021
Press release
Galderma to acquire award-winning ALASTIN Skincare® enhancing its integrated dermatology platform to continue delivering the best experience to patients
  • Global release
READ MORE
22 . 11 .2021
Press release
Galderma leads oral presentation on hyaluronic acid filler safety insights at ASDS 2021 Annual Meeting
  • U.S. release
READ MORE
30 . 09 .2021
Press release
RESTYLANE®, the original stabilized hyaluronic acid filler, celebrates 25 years of unmatched achievement
  • Global release
READ MORE
30 . 09 .2021
Press release
RESTYLANE® celebrates 25 years of natural-looking results with its signature line of hyaluronic acid fillers
  • U.S. release
READ MORE
29 . 09 .2021
Press release
Galderma presents new nemolizumab data at EADV reinforcing rapid onset of action and consistent relief of symptoms for people with prurigo nodularis and atopic dermatitis
  • Global release
READ MORE